Mirati Therapeutics (MRTX) Competitor Comparison
We are evaluating the key criteria listed to compare Mirati Therapeutics (MRTX) against its competitors in the Biotechnology industry.
Market Capitalization
41 / 368Gross Profits
277 / 278Total Revenue
134 / 300EBITDA
334 / 337Free Cashflow
341 / 352Quick Ratio
125 / 357Earnings per Share
340 / 359Dividend yield
0 / 6Total Cash
25 / 358Performance 3 years
211 / 368Performance 5 years
144 / 368Performance 10 years
47 / 368Linearity 3 years
162 / 368Linearity 5 years
8 / 368Linearity 10 years
164 / 368Total Rank
336 / 368Dividend Rank
206 / 368Valuation Rank
292 / 368Piotroski Rank
296 / 368Muliplier Rank
157 / 368Performance 10 years - MRTX ranking 47 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.